BreakSight is a genomics startup advancing the way cancer drugs are characterized. Our platform analyzes how precision oncology treatments damage DNA at the sequence level. By capturing and sequencing these unique patterns of DNA damage, we help researchers discover new biomarkers—genetic clues that... Read more
This company has no teams yet
This company has no offices yet